And those who took this small dose for 18 months also had less brain plaques associated with Alzheimer’s. Its mode of action?
STORY AT-A-GLANCE
- Curcumin, a bioactive ingredient in the spice turmeric, has over 160 potentially therapeutic activities, including anti-inflammatory, neuroprotective and anticancer benefits
- Research suggests curcumin may have long-term effects on your cognitive function by protecting against brain inflammation. By boosting mood, it may also help prevent depression
- Compared to controls, patients who took 90 mg of curcumin for 18 months experienced a 28 percent improvement in memory; brain scans also show they had less brain plaques associated with Alzheimer’s disease
- Research also suggests curcumin may offer potent protection against cancer, and it’s been shown to enhance conventional cancer treatments such as chemotherapy
- Consumed alone in its raw form, bioavailability of curcumin is poor; however, there are formulas and methods that improve absorption. The addition of piperine can increase absorption of curcumin by 2,000%
Studies suggest it can be a powerful ally in the treatment of depression, cancer, inflammatory bowel diseases and rheumatoid arthritis, for example. Many of curcumin’s benefits are attributed to its ability to quench inflammation, which is a hallmark of most chronic diseases, from obesity and metabolic syndrome to heart disease and dementia.
Importantly, it has the ability to cross your blood-brain barrier and exhibits potent neuroprotective properties, suggesting it may be useful for neurodegenerative disorders. Researchers at the University of California recently demonstrated it may have long-term effects on your cognitive function by protecting against brain inflammation.[1]
Curcumin May Protect Against Dementia
The double-blind, placebo-controlled study, published in the American Journal of Geriatric Psychiatry,[2] included 40 adults between the ages of 50 and 90 who reported mild memory lapses. None had a diagnosis of dementia at the time of their enrollment. Participants randomly received either 90 milligrams (mg) of curcumin (Theracurmin supplement) twice a day for 18 months, or a placebo.A standardized cognitive assessment was administered at the start of the study and at six-month intervals thereafter, and the level of curcumin in their blood was measured at the beginning and end of the study. Thirty of the participants also underwent positron emission tomography (PET) scans to assess their level of amyloid and tau deposits before and after treatment, which are strongly associated with Alzheimer’s risk.
“The researchers plan to conduct a follow-up study with a larger number of people. That study will include some people with mild depression so the scientists can explore whether curcumin also has antidepressant effects. The larger sample also would allow them to analyze whether curcumin’s memory-enhancing effects vary according to people’s genetic risk for Alzheimer’s, their age or the extent of their cognitive problems.
Curcumin — A Powerful Neuroprotectant
Curcumin has also been shown to increase levels of brain-derived neurotrophic factor (BDNF)[4] and this may be yet another mechanism that can help explain its neuroprotective effects.[5] Reduced levels of BDNF has been linked to both depression and Alzheimer’s disease.Curcumin Shown to Relieve Symptoms of Depression
As in the featured study, earlier research has also demonstrated curcumin’s mood-boosting effect, suggesting it may be helpful against depression. A 2017 meta-analysis[9] of six short-term, placebo-controlled clinical trials concluded curcumin “appears to be safe, well-tolerated and efficacious among depressed patients,” and could serve as a “novel antidepressant.” Three of the trials also reported significant anti-anxiety effects.Another recent study[10] evaluating curcumin’s effect on depression was done in Australia. A total of 123 people diagnosed with major depressive disorder were included in the double-blind, randomized study, receiving either 250 or 500 mg of curcumin extract, 250 mg of curcumin with 15 mg of saffron, or a placebo, for three months.
Compared to placebo, all three treatment groups experienced improvement in their symptoms. Curcumin was particularly effective for those with atypical depression. Interestingly, there was no significant difference in efficacy between the dosages. (On a side note, saffron has also been shown to have antidepressant effects in a number of studies,[11][12][13][14] which is why it was included in one of the treatment groups here.)
“[C]urcumin can influence an array of biological activities. Many of these, such as its anti-inflammatory, antioxidant, neuroprotective and monoaminergic effects are dysregulated in several neuropsychiatric disorders …